| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
44,149 |
30,928 |
$2.16M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
21,983 |
14,095 |
$1.28M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,679 |
6,888 |
$1.05M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,006 |
4,447 |
$624K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,540 |
2,617 |
$371K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
816 |
673 |
$304K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,564 |
1,352 |
$245K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,835 |
2,198 |
$229K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,005 |
2,629 |
$202K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
934 |
828 |
$168K |
| 96127 |
|
7,039 |
5,414 |
$165K |
| 92551 |
|
1,810 |
1,682 |
$132K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,618 |
2,433 |
$100K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
821 |
800 |
$96K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
965 |
702 |
$92K |
| 99215 |
Prolong outpt/office vis |
1,112 |
676 |
$68K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,526 |
1,097 |
$65K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
664 |
577 |
$63K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,730 |
5,422 |
$51K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
207 |
132 |
$45K |
| 80053 |
Comprehensive metabolic panel |
4,652 |
3,681 |
$41K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
398 |
299 |
$39K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,672 |
2,327 |
$37K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,185 |
3,985 |
$36K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,052 |
1,255 |
$35K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,408 |
2,179 |
$35K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
529 |
497 |
$35K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,706 |
4,389 |
$34K |
| 85027 |
|
5,920 |
4,873 |
$32K |
| 70450 |
Computed tomography, head or brain; without contrast material |
171 |
151 |
$31K |
| 81025 |
|
1,522 |
1,346 |
$26K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,103 |
982 |
$24K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
503 |
391 |
$24K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
569 |
491 |
$23K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
351 |
335 |
$23K |
| 90686 |
|
1,449 |
1,354 |
$23K |
| 81001 |
|
4,918 |
4,117 |
$22K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
327 |
307 |
$21K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
838 |
753 |
$20K |
| 90670 |
|
214 |
205 |
$20K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,265 |
2,092 |
$18K |
| 80061 |
Lipid panel |
1,699 |
1,561 |
$17K |
| 71046 |
Radiologic examination, chest; 2 views |
2,005 |
1,778 |
$17K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
219 |
197 |
$17K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
533 |
463 |
$16K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,174 |
1,853 |
$15K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,354 |
1,089 |
$13K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
90 |
79 |
$12K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
154 |
134 |
$11K |
| 84484 |
|
1,895 |
1,428 |
$10K |
| 85610 |
|
1,989 |
1,180 |
$10K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
247 |
229 |
$10K |
| 73630 |
|
675 |
521 |
$10K |
| 90651 |
|
113 |
109 |
$10K |
| 83605 |
|
1,569 |
1,141 |
$10K |
| 91320 |
|
183 |
176 |
$9K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
334 |
172 |
$8K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,250 |
2,716 |
$8K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
107 |
82 |
$7K |
| 82248 |
|
2,762 |
2,119 |
$7K |
| 87088 |
|
502 |
430 |
$6K |
| 83735 |
|
1,689 |
1,209 |
$6K |
| 99173 |
|
844 |
792 |
$6K |
| 0012A |
|
258 |
196 |
$6K |
| 83690 |
|
1,367 |
1,152 |
$6K |
| 90834 |
Psychotherapy, 45 minutes with patient |
347 |
177 |
$6K |
| 86140 |
|
1,606 |
1,318 |
$6K |
| 0011A |
|
265 |
207 |
$6K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
146 |
138 |
$5K |
| 87077 |
|
918 |
807 |
$5K |
| 36592 |
|
931 |
692 |
$5K |
| 87186 |
|
556 |
496 |
$5K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
263 |
223 |
$5K |
| 0001A |
|
217 |
169 |
$5K |
| 90715 |
|
220 |
210 |
$5K |
| 0002A |
|
166 |
140 |
$5K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,083 |
1,980 |
$5K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
89 |
53 |
$4K |
| 90734 |
|
76 |
69 |
$4K |
| 90480 |
|
228 |
217 |
$4K |
| 99188 |
|
359 |
346 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
16,297 |
12,739 |
$4K |
| 84145 |
|
355 |
295 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
98 |
94 |
$4K |
| 80076 |
|
517 |
402 |
$4K |
| 90661 |
|
173 |
166 |
$4K |
| 85018 |
|
570 |
478 |
$3K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
26 |
25 |
$3K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
66 |
46 |
$3K |
| 90674 |
|
180 |
177 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
182 |
102 |
$3K |
| 90633 |
|
119 |
115 |
$3K |
| 87210 |
|
258 |
227 |
$3K |
| 82728 |
|
207 |
191 |
$2K |
| 73562 |
|
111 |
83 |
$2K |
| 87634 |
|
38 |
36 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
82 |
77 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
72 |
44 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
36 |
32 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
401 |
358 |
$2K |
| 87081 |
|
191 |
179 |
$2K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
49 |
40 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,308 |
1,075 |
$2K |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
95 |
80 |
$1K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
19 |
13 |
$1K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
43 |
40 |
$1K |
| 0072A |
|
48 |
34 |
$1K |
| 97162 |
|
47 |
24 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,933 |
1,807 |
$1K |
| 86803 |
|
107 |
97 |
$1K |
| 96161 |
|
77 |
75 |
$1K |
| 0124A |
|
101 |
96 |
$1K |
| 82607 |
|
131 |
123 |
$1K |
| 36416 |
|
832 |
433 |
$1K |
| 82565 |
|
235 |
208 |
$1K |
| 0004A |
|
44 |
37 |
$1K |
| 87070 |
|
124 |
105 |
$1K |
| 90723 |
|
68 |
63 |
$1K |
| 99205 |
Prolong outpt/office vis |
17 |
15 |
$1K |
| 90791 |
Psychiatric diagnostic evaluation |
33 |
25 |
$918.61 |
| 82947 |
|
272 |
178 |
$893.00 |
| 84466 |
|
97 |
90 |
$847.64 |
| 90647 |
|
24 |
24 |
$840.37 |
| 0071A |
|
42 |
35 |
$800.64 |
| 90680 |
|
13 |
13 |
$795.60 |
| 0064A |
|
34 |
30 |
$774.98 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
26 |
25 |
$741.20 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
309 |
253 |
$651.92 |
| 82077 |
|
60 |
50 |
$511.34 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,049 |
1,601 |
$492.27 |
| 82570 |
|
156 |
137 |
$488.98 |
| 83540 |
|
99 |
92 |
$443.54 |
| 82043 |
|
52 |
50 |
$404.79 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,053 |
2,489 |
$395.95 |
| 73030 |
|
29 |
25 |
$379.97 |
| 90677 |
|
33 |
32 |
$308.72 |
| 84460 |
|
97 |
88 |
$248.72 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
704 |
596 |
$234.53 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
783 |
641 |
$201.93 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
141 |
53 |
$196.15 |
| 80306 |
|
13 |
12 |
$194.81 |
| 86618 |
|
16 |
12 |
$187.14 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
29 |
17 |
$182.62 |
| 81003 |
|
103 |
97 |
$174.42 |
| 82962 |
|
47 |
24 |
$173.20 |
| 83880 |
|
28 |
25 |
$162.28 |
| 90473 |
|
16 |
13 |
$162.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
14 |
12 |
$156.06 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
344 |
211 |
$148.74 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,029 |
1,630 |
$141.24 |
| 86780 |
|
15 |
13 |
$133.56 |
| 87205 |
|
56 |
50 |
$126.94 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
815 |
664 |
$107.76 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
637 |
528 |
$76.75 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
45 |
38 |
$70.06 |
| A9270 |
Non-covered item or service |
3,436 |
1,408 |
$66.66 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
258 |
203 |
$65.14 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
31 |
16 |
$62.88 |
| 90474 |
|
41 |
37 |
$43.95 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
425 |
314 |
$37.39 |
| 90662 |
|
48 |
45 |
$32.32 |
| 85652 |
|
14 |
12 |
$25.11 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
672 |
439 |
$22.87 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
236 |
172 |
$19.32 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
94 |
88 |
$10.04 |
| G0008 |
Administration of influenza virus vaccine |
446 |
422 |
$1.27 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,125 |
972 |
$0.25 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
486 |
390 |
$0.10 |
| 91301 |
|
13 |
12 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
189 |
118 |
$0.00 |
| 99417 |
Prolong home eval add 15m |
32 |
25 |
$0.00 |
| 0352U |
|
37 |
30 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
42 |
40 |
$0.00 |
| 90694 |
|
69 |
62 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
26 |
14 |
$0.00 |
| 90653 |
|
12 |
12 |
$0.00 |